Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
METHOD FOR THE DETECTION OF CONGENITAL NEPHROTIC SYNDROME
Document Type and Number:
WIPO Patent Application WO/2000/052023
Kind Code:
A1
Abstract:
The present invention is directed to a method for detection of congenital nephrotic syndrome of the Finnish type (NPHS1) by identification of mutated nephrin at a localized portion of the slit diaphragm area. The congenital nephrotic syndrome of the Finnish type (NPHS1), a disease in which the nephrin gene is mutated, is characterized by massive proteinuria already in utero and lack of slit diaphragm and foot processes. This, together with the now demonstrated localization of nephrin to the slit diaphragm area, suggests an essential role for this novel protein in the normal glomerular filtration barrier. A zipper-like model for nephrin assembly in the slit disphragm is discussed.

Inventors:
TRYGGVASON KARL (SE)
Application Number:
PCT/US2000/005507
Publication Date:
September 08, 2000
Filing Date:
March 02, 2000
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BIOSTRATUM INC (US)
TRYGGVASON KARL (SE)
International Classes:
C07K16/28; (IPC1-7): C07H19/00; C07H21/00; C07H21/02; C07H21/04; C12P19/34; C12Q1/68
Domestic Patent References:
WO1999047562A11999-09-23
Other References:
AHOLA ET. AL.: "Cloning and Expression of the Rat Nephrin Homolog", AMERICAN JOURNAL OF PATHOLOGY, vol. 155, no. 3, September 1999 (1999-09-01), pages 907 - 913, XP002928912
BOLK ET. AL.: "Elevated Frequency and Allelic Heterogeneity of Congenial Nephrotic Syndrome, Finnish Type, in the Old Order Mennonites", AM. J. HUM. GENETC., vol. 65, 1999, pages 1785 - 1790, XP002928913
DE LA CHAPELLE A.: "Disease gene mapping in isolated human populations: the example of Finland", J. MED. GENET., vol. 30, 1993, pages 857 - 865, XP002928914
HOLTHOFER ET. AL.: "Nephrin Localizes at the Podocyte Filtration Slit Area and Is Characteristically Spliced in the Human Kidney", AMERICAN JOURNAL OF PATHOLOGY, vol. 155, no. 5, November 1999 (1999-11-01), pages 1681 - 1687, XP002928915
KESTILA ET. AL.: "Exclusion of eight genes as mutated loci in congenital nephrotic syndrome of the Finnish type", KIDNEY INTERNATIONAL, vol. 45, 1994, pages 986 - 990, XP002928916
KESTILA ET. AL.: "Congenital Nephrotic Syndrome of the Finnish Type Maps to the long Arm of Chromosome 19", AM. J. HUM. GENET., vol. 54, 1994, pages 757 - 764, XP002928917
LAINE ET. AL.: "Post-tranplantation Nephrosis in Congenital nephrotic Syndrome of the Finnish Type", KIDNEY INTERNATIONAL, vol. 44, 1993, pages 867 - 874, XP002928918
LENKKERI ET. AL.: "Structure of the Gene for Congenital Nephrotic Syndrome of Finnish Type (NPHS1) and Characterization of Mutations", AM. J. HUM. GENET., vol. 64, 1999, pages 51 - 61, XP002928919
LJUNGBERG ET. AL.: "Congenital Nephrosis of the Finnish Type (CNF): Matrix Components of the Glomerular Basement Membranes and of Cultured Mesangial Cells", HISTOCHEMICAL JOURNAL, vol. 25, 1993, pages 606 - 612, XP002928920
MAHAN ET. AL.: "Congenital Nephrotic Syndrome: Evolution of Medical Management and Results of Renal Transplantation", THE JOURNAL OF PEDIATRICS, vol. 105, no. 4, October 1984 (1984-10-01), pages 549 - 557, XP002928921
MANNIKKO ET. AL.: "Fine Mapping and Haplotype Analysis of the Locus for Congenital Nephrotic Syndrome on Chromosome 19q13.1", AM. J. HUM. GENET, vol. 57, 1995, pages 1377 - 1383, XP002928922
MANNIKKO ET. AL.: "Improved prenatal Diagnosis of the Congenital Hephrotic Syndrome of the Finnish Type Based on DNA Analysis", KIDNEY INTERNATIONAL, vol. 51, 1997, pages 868 - 872, XP002928923
RAPOLA ET. AL.: "Congenital and Infantile Nephrotic Syndrome", GLOMERULAR DISEASES. IN: EDELMAN CM(ED) PEDIATRIC KIDNEY DISEASE, 2ND ED. LITTLE, BROWN AND COMPANY: BOSTON, vol. 2, 1992, pages 1291 - 1305, XP002928924
RUOTSALAINEN ET. AL.: "Nephrin is Specifically Located at the Slit Diaphragm of Glomerular Podocytes", PROC. NATL. ACAD. SCI. USA, vol. 96, July 1999 (1999-07-01), pages 7962 - 7967, XP002928925
TOPHAM ET. AL.: "Nephritogenic mAb 5-1-6 is Directed at the Extracellular Domain of Rat Nephrin", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 104, no. 11, December 1999 (1999-12-01), pages 1559 - 1566, XP002928926
Attorney, Agent or Firm:
Minnich, Richard J. (Fagan Minnich & McKe, LLP 1100 Superior Avenue Seventh floor Cleveland OH, US)
Download PDF:
Claims:
We claim:
1. A method for detection of susceptibility to congenital nephrotic syndrome of the Finnish type or the presence of congenital nephrotic syndrome of the Finnish type comprising identification of the presence of mutated nephrin at a localized region of the kidney.
2. The method of claim 1 wherein the localized region of the kidney is the podocyte slit diaphragm.
3. The method of claim 1 wherein the identification of the presence of mutated nephrin is through immunoelectron microscopy.
4. A method for detecting localization of nephrin in a tissue sample using a immunofluorescence microscopy comprising: a) generation of antibodies specific for nephrin; b) purification of said antibodies; c) generation of polyclonal antiserum into a kidney tissue sample to be analyzed for nephrin; d) introduction of said antiserum into a kidney tissue sample to be analyzed for nephrin; and e) analysis of said tissue sample by_ immunoelectron microscopy to detect for the presence of nephrin.
5. The method of claim 4 wherein the antibodies which are specific for nephrin are generated by isolating a protein which encodes for nephrin, purifying the protein, immunizing a rodent with a sufficient amount of the protein to generate an immune response, harvesting cells from said rodent, hybridizing said harvested cells with a suitable hybridization partner and screening the resultant hybridoma cells for said monoclonal antibody which is specific for nephrin.
6. An antibody generated by the method of claim 5.
7. A polyclonal antiserum, specific for nephrin, containing antibodies of claim 6.
8. A kit for detecting the localization of nephrin in a tissue sample comprising the antibodies of claim 6.
Description:
METHOD FOR THE DETECTION OF CONGENITAL NEPHROTIC SYNDROME FIELD OF THE INVENTION The present invention is directed to a method for detection of congenital nephrotic syndrome of the Finnish type (NPHS1). In particular, a method for detecting the presence of mutated nephrin at a localized portion of the slit diaphragm area is disclosed. Identification of the mutated nephrin at this localized area allows for detection of congenital nephrotic syndrome (NPHS1).

BACKGROUND OF THE INVENTION Ultrafiltration of blood during formation of the primary urine in the glomerulus is one of the central functions of the human kidney (Tisher, C. C., et al. (1996) in Anatomy of the kidney, eds. Brenner, B. M. & Rector, F.

C. (W. B. Saunders Company, Philadelphia), Vol. 1, pp.

3-71). Structurally, the glomerulus is a tuft of anastomosing capillary loops surrounded by the Bowman's capsule leading the primary urine to the tubular system.

The glomerular filtration barrier is formed by three layers: the innermost fenestrated vascular endothelium, the glomerular basement membrane (GBM), and the podocyte layer.

The podocytes form a tight web on top of the GBM with their interdigitating foot processes joined by a slit diaphragm.

It is generally acknowledged that the molecules passing through the glomerular filtration barrier are selected according to their size, charge and shape (Bohrer, M. P., et al. (1978) J. Clin. Invest., 61, 72-78; Brenner, B. M., et al. (1978) N. Engl. J. Med., 298,826-832; Batsford, S. R., et al. (1987) Kidney Int., 31,710-717; Kanwar, Y. S., et

al. (1991) Semin. Nephrol., 11,390-413; Ghitescu, L., et al. (1992) Kidney Int., 42,25-32; Fujigaki, Y., et al.

(1993) Kidney Int., 43,567-574; Remuzzi, A., et al. (1994) Kidney Int., 45,398-402). The exact locations of the various selective functions in the barrier are, however, more controversial. The charge-selective filter has been thought to be located in the GBM, a cross-linked meshwork of type IV collagen, laminin, nidogen and proteoglycans (Yurchenco, P. D., et al. (1993) in Supramolecular organization of basement membranes, eds. Rohrbach, D. H. & Timpl, R. (Academy Press, pp. 19-47); Hudson, B. G., et al.

(1993) J. Biol. Chem., 268,26033-26036). The anionic charge of heparin sulfate side chains of proteoglycans is believed to hinder the traversal of anionic plasma proteins (Kanwar, Y. S., et al. (1991) Semin. Nephrol., 11,390-413; Caulfield, J. P., et al. (1978) Lab. Invest., 39,505-512; Kanwar, Y. S., et al. (1979) J. Cell. Biol., 81,137-153).

The location of the size-selective property of the filtration barrier has been attributed to the GBM alone or, alternatively to the slit diaphragm (Kanwar, Y. S., et al.

(1991) Semin. Nephrol., 11,390-413; Karnovsky, M. J., et al. (1970) J. Ultrastruct. Res., 32,526-544).

Concerning the molecular composition of the slit diaphragm, monoclonal antibody 5-1-6 (Orikasa, M., et al.

(1988) J. Immunol., 141,807-814) that recognizes a 51 kDa protein has been shown in immunoelectron microscopy to react exclusively with the slit diaphragm (Am. J. Pathol., 147, 823-833 (1995)). However, the nature of this protein is still unknown. The a-isoform of the light junction protein ZO-1 (Schnabel, E., et al. (1990) J. Cell. Biol., 111, 125512-63) has been localized in the glomerulus, predominantly to points where the slit diaphragm is inserted into the lateral cell membrane of the foot process

(Kurihara, H., et al. (1992) Proc. Nad. Acad. Sci., 89, 7075-7079). The ZO-1 protein possibly connects the slit diaphragm, directly or indirectly, to the cytoskeleton.

In numerous primary and secondary diseases of the kidney, the filtration barrier is affected resulting in proteinuria, i. e., leakage of albumin and larger plasma proteins into the urine, with edema and nephrotic syndrome as a consequence. Many cases also include an immunological component in their etiology which, however, is not the case in the congenital nephrotic syndrome of the Finnish type (NPHS1) (Rapola, J. (1987) Pediatr. Nephrol., 1,441-446.).

We have recently identified the gene mutated in NPHS1 (Kestila, M., et al. (1998) Mol. Cell, 1,575-582; Lenkkeri, U., et al. Am. J Hum. Genet.). The disease specifically affects the kidney and is characterized by massive proteinuria already in utero. Electron microscopic examination of NPHS1 patient kidneys reveals thinner lamina densa of the GBM than in controls, but no structural abnormality of the GBM has been detected (Autio-Harmainen, H. (1981) APMIS, 89,215-222; Autio-Harmainen, H., et al.

(1983) Nephron, 34,48-50.). The podocyte foot processes are absent, a finding typical for nephrosis of any cause.

The gene mutated in NPHS1 codes for a putative transmembrane protein termed nephrin that belongs to the immunoglobulin (Ig) superfamily. It has an extracellular portion containing eight Ig-motifs and one type III fibronectin domain (Kestila, M., et al. (1998) Mol. Cell, 1, 575-582). This, together with the sequence of the intracellular domain which contains eight tyrosines, suggested that nephrin is a signaling adhesion molecule.

Using in situ hybridization, nephrin was shown to be exclusively expressed in glomerular podocytes (Kestila, M., et al. (1998) Mol. Cell, 1,575-582).

In accordance with the present invention nephrin was localized in immunofluorescence microscopy to the GBM region of newborn human glomeruli, using antibodies generated against recombinant antigen. It has now been demonstrated by the present invention through immunoelectron microscopy that nephrin is located in the podocyte slit region. As such, nephrin is most likely a component of the slit diaphragm. The fact that the protein is mutated in NPHS1, further indicates an essential role of nephrin for the slit diaphragm in the maintenance and size selectivity of the glomerular filtration barrier.

SUMMARY OF THE INVENTION In accordance with the present invention, a method for detecting the condition of congenital nephrotic syndrome of the Finnish type (NPHS1) is provided by identification of mutated nephrin at a localized portion of the slit diaphragm area of a kidney.

In a more particular aspect of the present invention, nephrin detection is carried out via immunoelectron microscopy thereby detecting for the presence of nephrin at the slit diaphragm of a kidney.

In a further aspect according to the present invention method, reagents and kits for screening individuals for the presence of mutated nephrin gene for diagnosis, pre-natal screening, or post-natal screening for susceptibility to glomerular nephrosis or basement membrane disease are provided. In particular, the present invention provides for screening for congenital nephrotic syndromes of the Finnish type (NPHS1).

These and other aspects and advantages will be more fully realized and appreciated upon a complete reading of the detailed description of the invention.

BRIEF DESCRIPTION OF THE DRAWINGS The invention will be better understood in view of the attached drawings wherein: Figure 1. Western blot analysis of glomerular and recombinant nephrin. A polyclonal anti-nephrin antibody reacts with a 180 kDa protein in a Triton X-100 extract of isolated normal human Orlomerull (A), and with a 150 kDa protein from the lysate of COS-7 cells transiently transfected with full-length nephrin cDNA (B). An additional band of over 300 kDa in size in the front of the gel can also be seen in the COS-7 cell extract. The nonreduced sample from human glomerular extracts, did not reveal any immunoreactive bands, indicating extensive disulfide crosslinking of nephrin, and only the 300 kDa band from COS-7 cell extract was present (not shown). The preimmune serum did not reveal any staining (not shown).

Figure 2. Immunohistochemical localization of nephrin in human kidney. Immunofluorescence staining was carried out on a 2-month-old human kidney with antibodies against recombinant human nephrin. Immunoreactivity is seen in the glomerulus, presumably at the podocyte-GBM junction. No staining is present in mesangial or endothelial cells.

Bar, 20 gm.

Figure 3. Immunoelectron microscopic localization of nephrin in human renal glomeruli. Indirect post-embedding staining for nephrin using affinity purified IgG against extracellular region of recombinant human nephrin and 10 nm. gold-coupled secondary antibody. A. Paraformaldehyde (PF) fixed kidney embedded in Lowicryl. Note gold label (arrowheads) between foot processes of podocytes (P). The label is located in the central area of the slit, between the glomerular basement membrane (GBM) and the faintly visible slit diaphragm (arrows). Endothelium (E) is unlabeled. Bar 200 nm). B. Several gold particles in a row

(box) can be seen between tangentially sectioned podocyte (P) foot processes. Gold particles in two other podocyte- podocyte interspaces are shown with arrowheads. Apparent intracellular staining of a podocyte (arrows) above glomerular basement membrane (GBM) could be due to grazing section of slit. Sample treated as in A. Bar, 500 nm. C.

Blow-up of in B. The row of 9 gold particles lies in tangentially cut, ca. 40 nm wide slit between two podocytes (P). Glomerular basement membrane is marked with asterisk.

Bar, 50 nm. D. Gold particle between slit diaphragm (arrow) joining two podocytes (P) and glomerular basement membrane (asterisk) in cross section. Sample fixed in 3.5% PF with 0.01% glutaraldehyde and embedded in LR White resin.

Bar, 50 nm.

Figure 4. Morphological structure of the glomerular podocyte slit diaphragm. Reproduced and modified from Rodewald and Karnovsky, (Kriz, W., et al. (1994) Kidney Int., 45,369-376). A. Electron microscopy of tannic acid stained and glutaraldehyde fixed rat glomerulus reveals the presence of a central filament and cross bridges. Density of the cytoplasm opposite the points of attachment of the slit diaphragm can be observed. Discontinuities in the diaphragm represent regions where the diaphragm has left the plane of section. B. Schematic model of the slit diaphragm.

The average cross-section dimensions of the pores between cross bridges are indicated within the rectangle.

Figure 5. Hypothetical model of nephrin assembly to form the isosporous filter of the podocyte slit diaphragm. A.

Schematic domain structure of nephrin. The Ig repeats are shown by incomplete circles connected by disulfide bridges (C-C). The locations of free cysteine residues are indicated by a-C. B. Possible mode of interdigitating association of four nephrin molecules in the slit between two foot processes. For the sake of clarity, nephrin

molecules from opposite foot processes are illustrated in different colors. In this model it is assumed that Ig repeats 1-6 of a nephrin molecule of one foot process associate in an interdigitating fashion with Ig repeats 1-6 in a neighboring molecule from the opposite foot process.

Cysteine residues are depicted by black lines and two potential disuffide bridges crosslinking four nephrin molecules in the center of the slit are illustrated. The remaining single free cysteine present in the fibronectin domain may react with another nephrin molecule, or some other, as yet unknown molecule, that may connect with the plasma membrane or cytoskeleton.

DETAILED DESCRIPTION OF THE INVENTION Congenital nephrotic syndrome of the Finnish type (CNF, NPHS1, MIM 256300) is an autosomal recessive disorder, and a distinct entity among congenital nephrotic syndromes. It is characterized by massive proteinuria at the fetal stage and nephrosis at birth. Importantly, NPHS1 appears to solely affect the kidney and, therefore, it provides a unique model for studies on the glomerular filtration barrier. The NPHS1 gene has been localized to 19ql3.1, and linkage disequilibrium has been used to narrow the critical region to 150 kilobases which were sequenced. As shown in PCT publication WO 99/47562 (Tyggvason, et al.), incorporated herein by reference, at least 10 novel genes, and one encoding amyloid precursor like protein were identified in this region. Five of the genes, all of which showed some expression in kidney, were analyzed by sequencing all their 63 exons in NPHS1 patients. Two mutations, a 2-bp deletion in exon 2 and a single base change in exon 26, both leading to premature stop codons were found in a novel 29-exon gene. The mutations were found either as homozygous or compound heterozygous in 44

out of 49 patients, 4 patients having the 2 bp deletion in one allele, the other potential mutation still being unknown. None among controls was found homozygous or compound heterozygous for the mutations. The gene product, termed nephrin, is a 1,241-residue putative transmembrane protein of the immunoglobulin family of cell adhesion molecules which by northern and in situ hybridization was shown to be kidney glomerulus-specific. The results demonstrate a crucial role for nephrin in the development or function of the kidney filtration barrier.

In accordance with the present invention, described herein is the generation and characterization of antibodies made against nephrin, the product of the gene mutated in patients with congenital nephrotic syndrome NPHS1. Based upon its primary structure, nephrin is most likely a signaling adhesion molecule belonging to the immunoglobulin superfamily. The present results, showing strong immunostaining of the GBM region in light microscopy and localization of nephrin to the slit diaphragm region by immunoelectron microscopy, provide the first evidence for the presence of a specific protein at this putative size-selective filter of the kidney. The fact that mutations in the nephrin gene lead to massive proteinuria, furthermore indicates that nephrin has a direct role or actual filtration function in this size-selective barrier.

The following example is intended to be illustrative, and not limiting, of the present invention and is provided to more fully understand the invention without limiting the scope thereof.

EXAMPLE Generation and Characterization of Antiserum The N-terminal fragment of nephrin was produced in Escherichia coli using QiaExpressionist-kit from Qiagen

(Qiagen Ltd., West Sussex, UK). The cDNA encoding amino acids 22 to 240 (Lenkkeri, U., et al., Am. J. Hum. Genet.) were amplified from human fetal kidney 5'STRETCH cDNA library (Clontech Laboratories Inc., Palo Alto, CA, USA) by PCR. Synthetic oligonucleotides were used to generate additional restriction sites BgIII (5') and HindIII (3') to the ends of the cDNA to facilitate cloning into BamHI/HindIII digested vector pQE-30. Production and initial purification of the six-histidine-tagged protein on Ni-NTA column was carried out according to the manufacturer's instructions. Protein was purified under denaturing conditions in phosphate buffer containing 8 M urea. For further purification, the protein was diluted 10-fold with an anion exchange chromatography buffer (8 M urea, 0.05 M Tris, I mM dithiotreitol, pH 8) and purified on Source Q column (Amersham Pharmacia Biotech, Sollentuna, Sweden) using a linear NaC1-gradient. Protein was precipitated by dialysis against phosphate buffered saline (PBS). The precipitate was solubilized in 1% SDS, diluted 10-fold with PBS and used as an antigen to raise polyclonal antibodies in rabbits using standard procedures (SLA, Uppsala, Sweden). The antisera were characterized using Western blotting, ELISA and immunofluorescence microscopy.

Purification of Antibodies For immunolocalization studies, rabbit IgG was affinity purified with protein A Sepharose FF (Amersham Pharmacia Biotech). For Western blot analysis, the antibody was purified using nitrocellulose bound recombinant antigen.

Briefly, two micrograms of antigen were separated by electrophoresis and blotted onto nitrocellulose membranes.

The antigen containing band was cut into pieces and blocked with bovine serum albumin (BSA). Antiserum was diluted ten-fold with TBS (0.05 M Tris, 0.15 M NaCl, pH 7.5) and

incubated with membrane pieces for two hours at room temperature. After four washings with TBS, bound antibodies were eluted with 0.1 M glycine, pH 3.5.

Western Blottina From isolated glomeruli the proteins were extracted into sonication buffer (0.05 M Na-phosphate, 0.15 M NaCI, 1% Triton X-100,0.1 mM phenylmethylsulfonyl fluoride and 10 mM ethylenediaminetetraacetic acid). Samples were treated with or without 10 mM dithiotreitol in sonication buffer.

After brief sonication, the samples were incubated on ice for 30 minutes and centrifuged to clear the supernatant.

For sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), the lysates were diluted in Laemmli sample buffer (LSB), either with or without 5% 2-mercaptoethanol and run on a 6% gel. COS-7 cells transiently expressing nephrin were treated similarly, except for that the reduction was done only prior to electrophoresis with mercaptoethanol.

SDS-PAGE and Western blot analyses were performed with standard methods (Laemmil, U. K. 1970) Nature, 227,680-5; Towbin, H., Staehelin, T. & Gordon, J. (1979) Proc. Nad.

Acad Sci., 76,4350-4354). Proteins were transferred onto PVDF membrane and blocked with 1% BSA in TBS. After anti- nephrin or preimmune IgG-incubation (0.1 ug,/ml), primary antibodies were detected with horseradish peroxidase conjugated anti-rabbit IgG (Dako, A/S, Glostrup, Denmark) and chemiluminescent reagent (ECLplus, Amersham Pharmacia Biotech).

Cloning of Full-Length Nephrin cDNA and Expression in COS-7 Cells.

A 2.4 kb PCR fragment was amplified from a fetal kidney cDNA library with primers selected from exons 1 and 17.

This PCR product was then used as a probe to screen the library for full-length cDNA. One clone was subcloned as two separate EcoRI fragments into pBluescript. PCR was used to introduce BglII restriction site upstream of the putative ATG initiator methionine site to facilitate the cloning into BamHI/EcoRl digested expression vector pcDNA3. The construct was sequenced and transfected into COS-7 cell line using the Fugene-6 transfection reagent (Boehringer Mannheim). These transiently transfected cells were used to characterize polyclonal antiserum with immunofluorescence microscopy and Western blotting.

Indirect Immunofluorescence Microscopy Cryosections of 5 to 10 um in thickness from a 2-month-old infant were placed on gelatine-coated slides and dried at room temperature. Sections were fixed in ethanol for 10 minutes at room temperature and washed in PBS.

Cultured cells were fixed with 4% paraformaldehyde for 3 minutes and then with ethanol for 10 minutes at room temperature. To block non-specific binding, the samples were incubated in 10% horse serum in PBS for 30 minutes at room temperature. Rabbit primary antisera were used at dilutions 1: 200 to 1: 400 in 1% horse serum in PBS.

Incubations were carried out for 2 hours at 37°C or overnight at 4°C. After washings in PBS the primary antibody was detected using FITC-labelled anti-rabbit IgG antibody (Dako) at dilution 1: 200 for 60 minutes at 37°C. After washings in PBS the sections were analyzed with fluorescence microscopy.

Immunoelectron Microscopy Kidney tissue from three brain-dead intended donors (a 49 year-old female unsuitable as donor due to HbsAg positivity, a 30 year-old female that was found to have variation in the kidney vasculature, and a normal 17 year-old male whose kidney was biopsied) were processed for post-embedding immunoelectron microscopy. The kidneys had been stored in ViaSpans solution (DuPont Merck Pharmaceutical Ltd., Herts, England) for 12,15, and 24 hours, respectably, until processing. Cubicles (lxlx5 mm) were cut with a razor blade from the renal cortex in PBS. The samples were fixed in 3.5% paraformaldehyde (Sigma, St Louis, Missouri, USA) alone or combined to 0.01% glutaraldehyde (Electron Microscopy Sciences, Fort Washington, PA, USA) in 0.1 M phosphate buffer (pH 7.3), at room temperature for 1,1.5, and 19 hours, respectably. Fixed samples were washed in phosphate buffer, dehydrated in graded ethanol and embedded in LR White (London Resin Company Ltd, Reading, Berkshire, England) and Lowicryl K4M (Polysciences Inc., Warrington, PA, USA) resins.

Thin sections were cut on Pioloform (Agar Scientific Ltd., Stansted, Essex, UK) and carbon coated nickel grids.

For indirect immunostaining, the grids were incubated in the first antibody diluted in 3% BSA-PBS (1: 100-200 for rabbit anti-nephrin whole serum, and to 10-50 ug/ml for the protein A affinity purified rabbit anti-nephrin IgG) for 60 min.

Grids were then treated with the second antibody (10 nm colloidal old goat anti-rabbit F (ab) 2, British BioCell International, Cardiff, UK, or 6 nm colloidal gold- affinipure goat anti-rabbit IgG, Jackson ImmunoResearch Laboratories, West Grove, PA, USA), diluted in 3% BSA-PBS (1: 50 or 1: 30) for 30 min at room temperature. The sections were examined under a Jeol 1200 EX electron microscope at 60 kV accelerating voltage.

RESULTS Characterization of Polyclonal Nephrin Antibodies Rabbit antiserum made against recombinant Ig repeats 1 and 2 of the amino terminal extracellular portion of human nephrin was shown to specifically react with full-length recombinant nephrin in Western blot analysis (Fig. 1).

Antibodies were also shown to be reactive in ELISA against the antigen, as well as in immunofluorescence microscopy against COS-7 cells transfected with full-length nephrin cDNA. Moc-transfected cells did not yield immunoreactivity (data not shown). The antiserum reacted with a 180 kDa protein present in Triton X-100 extracts of human glomeruli (Fig. 1). Full-length recombinant nephrin produced in COS-7 cells has a smaller size of-150 kDa. The sequence predicted molecular weight of nephrin, without postranslational modifications, is 134 kDa (Kestila, M., et al. (1998) Mol. Cell, 1,575-582).

Using these antibodies, nephrin was localized to glomeruli of newborn human kidney cortex by immunofluorescence microscopy (Fig. 2). Immunoreactivity was observed in the GBM region, while the podocyte cell bodies, as well as endothelial and mesangial cells, were negative. No specific reactivity of these antibodies against other kidney structures could be detected when compared with pre-immune serum (not shown). These results agree with our previous in situ hybridization data showing specific expression of the nephrin gene in visceral epithelial cells (podocytes) of human glomeruli (Lenkkeri, U., et al., Am. J. Hum. Genet.). The present immunostaining pattern, together with the previous in situ hybridization results, suggest that the transmembrane protein nephrin is located either in the podocyte-GBM interface and/or in the slit diaphragm between the podocyte foot processes.

Localization of Nephrin to the Glomerular Slit Diaphragm by Immunoelectron Microscopy In order to more precisely determine the location of nephrin, post-embedding immunoelectron microscopy was carried out. Affinity purified rabbit anti-nephrin IgG was found to give much less background staining, as compared to anti-nephrin serum. With the purified IgG against the extracellular fragment of nephrin, immunogold label was, in practice, exclusively found in the podocyte slit diaphragm region between the podocyte foot processes (Fig. 3). In cross sections of the GBM (Fig. 3 A, D), one or two gold particles could, in general, be detected approximately in every fifth to tenth foot process interspace. Rarely, gold label could be observed in the cytoplasm of a foot process.

No label was seen between the podocyte foot processes and the GBM. Neither endothelial nor mesangial cells were labeled. With the protocol used, background labeling with the affinity purified anti-nephrin IgG was practically absent. In the more parallel sectioned GBM areas, several (up to nine) gold particles could be observed in a slit (Fig. 3 B, C). With increasing glutaraldehyde concentrations, better ultrastructure but reduced label was seen. Immunogold staining with affinity purified pre-immune serum IgG, with an equivalent protein concentration, was negative (not shown).

Discussion The remarkable interdigitating pattern of adjacent podocyte foot processes in the kidney glomerulus has implied an essential role of the podocytes for the integrity of the glomerular filtration barrier (Mundel, P., et al. (1995) Anat. Embryol., 192,385-397; Kriz, W., et al. (1994) Kidney Int., 45,369-376; Daniels, B. (1993) Am. J Nephrol., 13, 318-23). Much interest. in the study of this barrier has been focused on the cell junction between the foot processes, the so called slit diaphragm. However, the actual molecular structure of the diaphragm remains still to be unraveled. In accordance with the present invention, described herein is the generation and characterization of antibodies made against nephrin, the product of the gene mutated in patents with congenital nephrotic syndrome NPHS1.

Based upon its primary structure, nephrin is most likely a signaling adhesion molecule belonging to the immunoglobulin superfamily. The present results, showing strong immunostaining of the GBM region in light microscopy and localization of nephrin to the slit diaphragm region by immunoelectron microscopy, provide the first evidence for the presence of a specific protein at this putative size-selective filter of the kidney. The fact that mutations in the nephrin gene lead to massive proteinuria (Kestila, M., et al. (1998) Mol. Cell, 1,575-582; Lenkkeri, U., et al., Am. J Hum. Genet.) furthermore indicates that nephrin has a direct role or actual filtration function in this size-selective barrier.

Concerning nephrin localization it should be stressed that, in its extracellular labeling, nephrin was found only between the foot processes. It was conspicuously lacking from the interspaces between the foot processes and the GBM, a site with very much larger potential labeling surface than

present in the narrow slit. The possible deviation of the antigenic epitope from the visible gold label, using the rabbit anti-nephrin/gold F (ab) 2 anti-rabbit complex, can be estimated to be up to 1.5 x length of the IgG molecule (Valentine, R. C., et al. (1967) J. Mol. Biol., 27, 615-617), i. e., about 15 nm. Therefore, the precise molecular location and orientation of nephrin in the approximately 35-45 nm wide slit remains to be determined.

However, some clues are now available from the present results. In some cases, rows of up to nine gold particles long were found in favorable tangential sections (Fig. 3 B, C). This suggests that a linear array of antigenic sites parallel to the GBM surface would exist at some height along, the slit, possibly in the slit diaphragm itself. The gold particles on the IgG complexes might, however, line up also under the influence of other molecular determinants in their surroundings.

The occasional cases of gold label observed in the cytoplasm of foot processes, if not the result of tangential sectioning, may represent newly synthesized nephrin molecules. The labeling intensity with the method used in this study was not expected to be very high as the antibodies are directed only against a small, maybe often unexposed portion of nephrin. Therefore, the finding of label in only 10-20% of the slits in the ultrathin cross sections is not surprising. Preliminary results with immunogold labeled cryosections reveal a higher labeling intensity of the slit diaphragm between well preserved podocyte foot processes.

The present results raise the fundamental question as to how a protein like nephrin, either alone or together with other slit membrane protein (s), can contribute to the molecular structure of a porous filter. The ultrastructure of the podocyte slit diaphragm has been studied extensively

by electron microscopy (Mundel. P., et al. (1995) Anat.

Embryol., 192,385-397). Rodewald and Karnovsky (Rodewald, R., et al. (1974) J. CeIl Biol., 40,423-433) were the first to suggest a zipper-like organization of this structure (Fig. 4). As these studies used the conventional thin-sectioning method requiring harsh chemical treatments in sample preparation, it has later been suggested that the zipper-looking structure might be due to an artifact. Since then, the podocyte-podocyte junction has also been studied by several other electron microscopic methods (Furukawa, T., et al. (1991) Kidney Int., 40,621-624; Ohno, S., et al.

(1992) Virchows Arch. B. Cell. Pathol., 61,351-8). These studies have indicated that the width of this junction varies between 20 and 50 nm. The actual slit diaphragm is considered to be a rather rigid structure. However, it has recently been suggested that at least the slit area might increase with increasing perfusion pressures of the glomerulus (Yu, Y., et al. (1997) Nephron, 76,452-459; Kriz, W., et al. (1996) Kidney Int., 49, 1570-1574). Since the actual molecular structure of the slit diaphragm is, as yet, unresolved, it is precocious to speculate on a molecular assembly allowing change in the width of the slit. Results as shown herein, however, provide evidence that nephrin is a component of such an assembly. This calls for further studies on the molecular structure of the slit diaphragm.

Several lines of evidence indicate that nephrin may assemble into a zipper-like isosporous filter structure similar to that presented by Rodewald and Karnovsky (Rodewald, R., et al. (1974) J. CeT. Biol., 40,423-433) (Fig. 4). First, the present invention demonstrates that nephrin is specifically located at the slit diaphragm.

Second, nephrin must be crucial for the structural integrity of the slit diaphragm, as absence of the protein or current

amino acid substitutions causes congenital nephrosis, a lack of the slit diaphragm with massive proteinuria as a result (Lenkkeri, U., et al., Am. J. Hum. Genet.). Third, nephrin molecules extending towards each other from two adjacent foot processes are likely to interact with each other in the slit through homophilic interactions, as has been shown for other Ig cell adhesion molecules, such as N-CAM (Kiselyov, V. V., et al. (1997) J. Biol. Chem., 272,10125-10134), C-CAM (Obrink, B. (1997) Curr. Opin. Cell. Biol., 9,616-626) and Ll (Sonderegger, P. et al. (1992) J. Cell Biol., 119, 1387-1394.). Fourth, such homophilic assembly of nephrin molecules in the slit could have a zipper-like arrangement, essentially, as that proposed based on electron microscopic studies (Figs 4 and 5).

A hypothetical head-to-head assembly of nephrin through homophilic interactions is illustrated in Fig. 5. The amino terminal extracellular domain of nephrin contains six consecutive Ig repeats, followed by a spacer domain, two additional Ig repeats, and one fibronectin type III-like domain (Fig. 5 A). Each Ig motif contains two cysteine residues that, similarly to corresponding motifs in other proteins (Chothia, C., et al. (1997) Annu. Rev. Biochem., 66,823-862), can be assumed to form a disulfide bridge within the repeat structure (Fig. 5 A). Ig motifs have been shown to adopt a globular or ellipsoid structure with an average axis length between 24 and 47 A, averaging 35 A (Holden, H. M., et al. (1992) J. Mol. Biol., 227,840-851).

If the Ig repeats were to form a chain-like structure, as has been proposed for Ig cell adhesion molecules, all eight motifs would contribute to a length of about 28 nm. The region between Ig repeats 6 and 7 and fibronectin type III -like domain would add more length to the protein.

Consequently, a single nephrin molecule can extend through most of the width of the 35-45 mn wide slit diaphragm.

In addition to the two cysteine residues in each Ig motif, nephrin contains three free cysteines, one in Ig motif 1, one in the spacer region between Ig motifs 6 and 7, and one in the fibronectin domain close to the plasma membrane. The three free cysteines are likely to have a function in forming intermolecular disulfide bridges that provide strength to the slit diaphragm. These cysteines are important as their absence results in proteinuria and congenital nephrotic syndrome. In the hypothetical model presented here, the free cysteine of Ig motif 1 in one molecule interacts with the cysteine residue of the spacer in another nephrin molecule. Such disulfide bonds could "lock"the homophilic unit of six Ig repeats of one nephrin molecule to similar units of two adjacent nephrin molecules.

A centrally located aggregate of numerous nephrin molecules along the slit between two foot processes could constitute the central filament visualized by Rodewald and Karnovsky (Rodewald, R. et al. (1974) J. Cell Biol., 40,423-433) (Fig. 4 A). The width of the central aggregate would be 21 o nm (6x35 A) by simply assuming a linear chain arrangement of <BR> <BR> <BR> <BR> six Ig repeats, 35 Å each, and this would not agree with the 11 nm width of. the central filament reported by Rodewald and Karnovsky (Rodewald, R., et al. (1974) J. Cell Biol., 40,423-433). However, this difference could be attributed to the shrinkage of tissues that occurs during sample preparation. Also, the mode of packing of Ig modules may well be different from that presented in the model, so that it is still possible that nephrin forms the basis of the slit diaphragm through homophilic interactions.

In conclusion, the recent identification of nephrin and its present specific localization to the podocyte slit diaphragm may accelerate the elucidation of the molecular

structure of the size-selective glomerular filtration barrier. The model for nephrin assembly into a slit diaphragm as set forth herein, supports the model for slit diaphragm ultrastructure presented over two decades ago based on transmission electron microscopy. In addition, there are potential other functions of nephrin, such as its potential signaling role. The elucidation of the molecular structure of the filtration barrier can have significant clinical value, as it may help understand the pathogenic mechanisms of proteinuria in numerous of genetic and acquired diseases that affect the kidney and lead to proteinuria.

The invention has been described with reference to the preferred embodiments. Obviously, modifications and alterations will occur to others upon a reading and understanding of this specification. It is intended to include all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalence thereof.